EU Unitary Patent

The EU Unitary Patent (officially 'European Patent with Unitary Effect' or 'Unitary Patent Protection') is a new form of patent protection that became operational on June 1, 2023. Unlike a classical European Patent (EP), which must be individually validated in each EPC contracting state after grant, a Unitary Patent provides automatic patent protection in all participating EU member states simultaneously from a single EPO grant. How it works: after the EPO grants a European Patent through the standard examination process, the patentee can request Unitary Effect within one month of the date of grant. This request, filed with the EPO, converts the granted European Patent into a Unitary Patent automatically covering all EU member states that have ratified the Unitary Patent system. As of June 1, 2023, 17 EU member states participate: Austria, Belgium, Bulgaria, Denmark, Estonia, Finland, France, Germany, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Portugal, Romania, Slovenia, and Sweden. What the Unitary Patent is NOT: it is not a substitute for validation in non-EU EPC contracting states (UK, Switzerland, Norway, Turkey, Morocco, Tunisia, Albania, etc.) or non-participating EU states (Spain, Croatia). Patentees who want protection in those countries still need classical national validation. The Unitary Patent exists alongside — and does not replace — the classical EP validation system. Patentees can choose one or the other (or both in a mixed strategy: Unitary Patent + classical validation in non-participating states).

The Unified Patent Court (UPC) is a new specialized international court created to adjudicate patent infringement and validity disputes for both Unitary Patents and classical EP patents (unless opted out). It became operational on June 1, 2023, on the same date as the Unitary Patent. The UPC's jurisdiction covers: (1) infringement of Unitary Patents and opted-in classical EP patents; (2) declarations of non-infringement; (3) revocation (invalidity) actions against Unitary Patents and opted-in classical EP patents; (4) provisional measures and preliminary injunctions; (5) compensation claims. Structure of the UPC Court of First Instance: local divisions in individual member states (Germany alone has four local divisions: Munich, Düsseldorf, Hamburg, Mannheim — the largest share given Germany's position as Europe's most patent-litigated jurisdiction); regional divisions for clusters of smaller states (Nordic-Baltic); Central Division for actions where the defendant has no EU domicile or for standalone revocation actions (originally London/Paris/Munich but reallocated after UK withdrawal from the Agreement). Court of Appeal: Luxembourg, ensuring pan-European consistency. Why the UPC matters: a UPC preliminary injunction can stop a defendant's activities across all 17+ participating states in a single order. A UPC final judgment of infringement covers all participating states. Similarly, a UPC revocation decision cancels the patent in all participating states simultaneously. For defendants: the UPC's central attack allows a single invalidity action to eliminate the patent everywhere — much more powerful than national court invalidity proceedings, which only affect the national designation.

The annual renewal fee for a Unitary Patent is paid to the EPO as a single fee, replacing all national renewal fees in participating states. The fee schedule was set to approximate the combined renewal fees of the four countries with the highest renewal fees in EPC contracting states — historically Germany, France, UK (now departed), and Netherlands. However, the UK's withdrawal from the Unitary Patent system after Brexit means the comparative basis has shifted. The EPO Unitary Patent renewal fee schedule (approximate) from EPO-published Schedule: Year 2 = €35; Year 3 = €105; Year 4 = €145; Year 5 = €315; Year 6 = €475; Year 7 = €630; Year 8 = €815; Year 9 = €990; Year 10 = €1,175; Year 11 = €1,460; Year 12 = €1,775; Year 13 = €2,105; Year 14 = €2,455; Year 15 = €2,830; Year 16 = €3,240; Year 17 = €3,640; Year 18 = €4,055; Year 19 = €4,455; Year 20 = €4,885. Break-even analysis: for patentees who currently validate in 4 or more European countries, the Unitary Patent's single renewal fee typically costs less than combined national renewal fees from around Year 4-5 onward. For patentees who validate in only 2-3 major countries, classical validation may remain cheaper because they were already avoiding the long-tail of small-country renewal fees. Translation costs during the transitional period: during the transitional period (up to 6 years), a full translation of the patent into one other EU official language (English patents → any EU language; non-English grants → English) is required. This translation cost must be factored into the Unitary Patent total cost. After the transitional period, no translation is required.

The central attack risk is the most significant strategic consideration for patentees deciding whether to opt their classical EP patents into the UPC's jurisdiction. In the pre-UPC system, an EP patent could only be invalidated country by country in national courts. An invalidity action in Germany only affected the German national part of the EP patent — the French, Italian, and Dutch designations remained valid. A competitor wanting to invalidate an EP patent across all countries had to file separate invalidity actions in each national court, which is expensive and time-consuming. Under the UPC, a single central revocation action filed in the UPC Central Division can invalidate a Unitary Patent or opted-in classical EP patent across ALL participating states in one proceeding. This is analogous to how the EPO Opposition procedure (within 9 months of grant) can revoke a patent across all EPC states — but UPC central revocation is available at any time, not just within 9 months of grant. Who faces this risk: (a) high-value pharmaceutical patents — a generic drug company can file one UPC revocation action to clear the market across 17 states; (b) widely-enforced technology patents — a market entrant facing infringement actions across Europe can countersue with one UPC revocation; (c) patents with known validity questions from EPO prosecution. Who is less at risk: (a) patentees holding patents with strong prosecution histories; (b) patentees in fragmented technology sectors where competitors lack resources for sophisticated UPC litigation; (c) patentees primarily using patents defensively rather than offensively. The opt-out (available during the 7-year transitional period until June 2030) is the primary tool for avoiding central attack risk — keeping the patent in national courts means any invalidity attack must be filed separately in each country.

The choice between Unitary Patent and classical EP validation depends on five factors: (1) Number of countries you actually need: if you need coverage in 5 or more EU participating states, the Unitary Patent almost always wins on cost (one renewal fee vs. five or more sets of national renewal fees + translations + local attorney fees for renewals). If you only need 1-2 countries, classical validation is cheaper. (2) Enforcement strategy: if you are likely to need pan-European enforcement (injunctions across multiple EU markets), the UPC is a powerful tool — one action, pan-European remedy. Choose Unitary + UPC. If you rarely litigate patents, or your threat is primarily national (e.g., your only infringement concern is in Germany), national courts via opt-out may be better. (3) Central attack risk tolerance: if the patent is high-value and validity is uncertain, opt out to keep it in national courts. If the patent has a clean prosecution history and strong claims, staying in the UPC is less risky. (4) Jurisdiction coverage: for countries not covered by the Unitary Patent (UK, Switzerland, Norway, Spain, non-EU EPC states), you need classical validation regardless. A mixed strategy (Unitary Patent + classical validation in UK/Switzerland/Spain) is common. (5) Timing: for EP applications that were granted after June 1, 2023, you must decide within 1 month of grant whether to request Unitary Effect. There is no going back — once you validate classically, you cannot convert to a Unitary Patent. For EP applications filed before June 1, 2023 and granted after, the same 1-month window applies. Recommendation for most portfolios: request Unitary Effect as a default for broad European coverage, opt out during the transitional period for the 5-10% of highest-value patents where central attack risk is material, and supplement with classical national validation in Spain, UK, and other non-participating states as needed.